Posts - Bill - HR 5158 Fair Price Device Act
house 09/04/2025 - 119th Congress
We are working to update the approval process for combination products that include generic drugs and devices, ensuring that safety and effectiveness are thoroughly evaluated when these products are used together. Our goal is to provide clearer guidelines so patients can trust that these combinations perform as safely and effectively as the original versions.
Congress.gov
HR 5158 - Fair Price Device Act
Views
right-leaning 09/04/2025
Federal micromanagement strikes again—letting experts do their job means less government meddling.
moderate 09/04/2025
Balancing innovation with safety—this bill tries to thread that needle without pissing off too many folks.
left-leaning 09/04/2025
This isn’t just about drugs and devices—it’s a win for transparency and accountability in Big Pharma’s playground.
moderate 09/04/2025
Sounds like a sensible tweak to make sure the drug-device combos actually do what they say on the label.
left-leaning 09/04/2025
Finally, a bill that puts patient safety before corporate shortcuts—about time someone looked out for the little guy!
moderate 09/04/2025
A bit of extra paperwork, sure, but if it means safer meds, maybe it’s worth the hassle.
right-leaning 09/04/2025
If we wanted safer drugs, we’d trust the market, not more bureaucrats writing endless rules.
right-leaning 09/04/2025
Another red tape fest disguised as ‘safety’ that’ll slow down medicine and jack up prices.
left-leaning 09/04/2025
If we want cheap generics, they better be safe generics. This bill demands both, no compromises.